Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
about
Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advancesCirculating tumor DNA in hepatocellular carcinoma: trends and challengesHost nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinomaRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaEnvironmental epigenetics and its implication on disease risk and health outcomesSirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathwayHumanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdoseImpact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinomaGlutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma.Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.Glutathione S-conjugates as prodrugs to target drug-resistant tumors.Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma.GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients.Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.Alpha-class glutathione S-transferases in wild turkeys (Meleagris gallopavo): characterization and role in resistance to the carcinogenic mycotoxin aflatoxin B1Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinomaQuantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumorsDNA methylation and regulation of the CD8A after duck hepatitis virus type 1 infection.Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients.Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.Hepatitis B virus infection in hepatocellular carcinoma tissues upregulates expression of DNA methyltransferases.Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas.Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.Endocrine disruption of the epigenome: a breast cancer link.Genome-wide DNA methylation profiles in hepatocellular carcinoma.Rapid identification of promoter hypermethylation in hepatocellular carcinoma by pyrosequencing of etiologically homogeneous sample poolsEpigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer TherapeutiHypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma.GSTP1 negatively regulates Stat3 activation in epidermal growth factor signaling.Glutathione S-transferase P1 correlated with oxidative stress in hepatocellular carcinomaGlutathione s-transferase p1: gene sequence variation and functional genomic studies.Specific mutations of hepatitis B virus in plasma predict liver cancer development.Critical analysis of the potential for targeting STAT3 in human malignancy.Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral statusDNA methylation in hepatocellular carcinoma.LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell ProliferationMolecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.Epigenetic reprogramming of host genes in viral and microbial pathogenesisHepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis.Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes.
P2860
Q26745338-E6E488B5-B4A5-402F-8242-38F2FF7AA194Q26749417-680957A0-5660-47A2-BD48-CE252970FB23Q26750792-56E4F87C-99F0-48D4-8C01-1E979876D3FAQ27023524-527C9AF8-469B-4916-89D0-8A175790449DQ28385993-8C48B6FF-30AB-4A70-AAB8-721C0E281D57Q28468627-89F79381-639B-48EC-A073-3E12A9554877Q28477445-AB2C2168-6BEF-4FD3-A9C3-353B380F29E0Q28730441-F6358BC3-3FF2-4D6E-8F15-CFA20D5E4944Q33544926-F5EA1930-08B9-4390-A83A-812DDC2CC735Q33831996-1031D07D-835F-4A43-A39A-317532A6229CQ34024771-085EDDA7-F0C7-4B7F-94C2-C173C1767FAFQ34294657-BE482670-EDCB-4AB5-89C4-D272456294B9Q34316742-7279F57A-4D8E-447F-9C44-195A9401C1BFQ34598189-FF0A8960-F143-49F5-91F3-E678A059FFB4Q34683728-FBC457D3-7128-41B7-B9F0-497AE33D3E43Q35000109-CA2017DF-BF48-45FB-9B96-111CBEABDD32Q35008011-5CDF0002-50D0-4FA1-B152-CDB6C5FB7BB7Q35088405-8E5ADB98-F9AD-45B9-ACDA-F688F2D866FEQ35375709-6C807647-E6D0-4211-ADB2-247946887C8CQ35615943-4D20E754-F91D-4698-BD43-B0EEFBA3E036Q35643951-DB77AA0B-61FB-460B-9EF5-FA86305DEC2CQ35658932-C80E1754-A8D0-4BAC-BE02-156DB9163420Q35793851-7226459D-48FD-42AE-9E26-5173E1CE5FDBQ35856594-27CFAADC-6DCE-4340-A918-2DF1C23EFD7DQ35899166-39AF9132-3869-43B6-B4F8-89146644CB87Q35988103-FA1E3D1A-080B-4163-AC0C-3774F34E1374Q36222932-6E171C54-013D-4122-A315-5AA9A0EF744EQ36611455-00426E54-5D52-4B63-B885-A9D0E2F813CFQ36621556-53E941A9-FB20-4754-91C2-0E751F22F87BQ36746926-77B333D2-CC9E-49DC-8728-FA91F9501C3DQ36798838-79B9FA4E-0169-4E2D-A559-8FAC3A58CBA0Q37074286-F648AC0C-415E-40CD-AFBB-30D494AB968AQ37075035-41769553-A27B-41F6-B0CF-FBFB01B91494Q37082686-17D38A9E-6C9D-4720-95B8-286956883511Q37113559-F28AE801-ADED-4AB6-AB21-7562E3B4F0E0Q37351582-CA55A95B-103D-49C7-B744-611913A4971BQ37407115-BB5D8498-C67F-4481-80CE-78682EDD8CCFQ37781197-29C213E0-EA7B-40A9-98C5-F28C72D7C784Q38110262-BCAAFEE7-EA4E-4F0B-A4AF-23FA532E9C6BQ39437275-509B4444-D409-42A6-8878-79D5A75A5026
P2860
Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Silencing of GSTP1 gene by CpG ...... ted hepatocellular carcinomas.
@en
Silencing of GSTP1 gene by CpG ...... ted hepatocellular carcinomas.
@nl
type
label
Silencing of GSTP1 gene by CpG ...... ted hepatocellular carcinomas.
@en
Silencing of GSTP1 gene by CpG ...... ted hepatocellular carcinomas.
@nl
prefLabel
Silencing of GSTP1 gene by CpG ...... ted hepatocellular carcinomas.
@en
Silencing of GSTP1 gene by CpG ...... ted hepatocellular carcinomas.
@nl
P2093
P1476
Silencing of GSTP1 gene by CpG ...... ated hepatocellular carcinomas
@en
P2093
Cuiling Liu
Mandy W Tang
Philip J Johnson
Sheng Zhong
Winnie Yeo
Y M Dennis Lo
P304
P407
P577
2002-04-01T00:00:00Z